Healthtech Investors & VC Firms in United States
657 firms in this list, with a median first check of $500K. 74 of them lead rounds. Generated from verified public data and updated continuously.
Oxford Finance LLC
AlexandriaSeed–Late Stage$500K – $40M
11 people
PAI Partners
Paris$108M – $324M
11 people
Sante Ventures
AustinSeed–Series A$2M – $6M
11 people
Verdane
OsloGrowth$21.6M – $162M
11 people
Viola Credit
Tel AvivGrowth–Late Stage$2M – $50M
11 people
World Innovation Lab (WiL)
TokyoSeed–Late Stage$5M – $30M
11 people
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
11 people
Refactor Capital
Silicon ValleySeed–Series A$1M – $2M
2 people
Avego BioScience Capital
AlpharettaSeries B–Late Stage
Borealis Ventures
HanoverPre-Seed–Seed$1M – $2.5M
4 people
China Growth Capital
BeijingPre-Seed–Series A
3 people
Figure 8 Investments
Western NCSeed–Series B
3 people
Next Ventures
AustinSeed–Series A$500K – $3M
3 people
South Loop Ventures
HoustonPre-Seed–Seed
3 people
Fika Ventures
Culver CitySeed–Series A$250K – $2M
8 people
Frist Cressey Ventures
NashvilleSeed–Series B
11 people
HC9 Ventures
HavertownSeed–Series A
6 people
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
Ballast Point Ventures
TampaGrowth–Late Stage$5M – $15M
10 people
Next Level Ventures
Des MoinesSeed–Late Stage$500K – $5M
10 people
Gore Range Capital
SouthlakeSeed–Late Stage$500K – $5M
3 people
Fly Ventures
BerlinSeed–Series A$1.1M – $4.3M
8 people
Crossroads Health Ventures
Pre-Seed–Series A
6 people
Equitage Ventures, L.L.C.
DenverPre-Seed–Late Stage$250K – $2.5M
3 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.